Oppenheimer & Co’s Tyra Biosciences TYRA Stock Holding History

Oppenheimer & Co’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.79M	Sell	82,072 -1,711	-2%	-$47K	0.02%	668
2026 Q2	$2.68M	Sell	83,783 -409	-0.5%	-$13.5K	0.03%	554
2026 Q1	$3.22M	Sell	84,192 -534	-0.6%	-$17.3K	0.04%	448
2025 Q4	$2.23M	Buy	84,726 +2,488	+3%	+$45.7K	0.03%	517
2025 Q3	$1.15M	Buy	82,238 +8,205	+11%	+$93.6K	0.01%	828
2025 Q2	$708K	Sell	74,033 -772	-1%	-$7.34K	0.01%	1008
2025 Q1	$696K	Sell	74,805 -634	-0.8%	-$8.2K	0.01%	955
2024 Q4	$1.05M	Sell	75,439 -1,367	-2%	-$24.8K	0.02%	765
2024 Q3	$1.81M	Buy	76,806 +6,318	+9%	+$133K	0.03%	588
2024 Q2	$1.13M	Buy	70,488 +10,912	+18%	+$188K	0.02%	727
2024 Q1	$977K	Buy	+59,576	New	+$977K	0.02%	747

Other funds holding TYRA

Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Auour Investments Woburn, Massachusetts $353M AUM 8.66% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Oppenheimer & Co's TYRA Position: Q3 2026 in Review

Oppenheimer & Co reduced its Tyra Biosciences (TYRA) stake by 2% in Q3 2026, selling an estimated $47K and leaving 82,072 shares worth $1.79M. The position accounts for 0.02% of the portfolio, ranked #668.

Oppenheimer & Co first reported a position in TYRA in Q1 2024 and has held it in 11 quarters since. The position peaked at $3.22M in Q1 2026. 32 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

Oppenheimer & Co held 82,072 shares of Tyra Biosciences worth $1.79M as of Q3 2026.
Oppenheimer & Co sold 1,711 Tyra Biosciences shares in Q3 2026, an estimated $47K.
Tyra Biosciences made up 0.02% of Oppenheimer & Co's portfolio in Q3 2026, its #668 holding.
Oppenheimer & Co first reported a position in Tyra Biosciences in Q1 2024 and has held it in 11 quarters since.
Oppenheimer & Co's Tyra Biosciences position peaked at $3.22M in Q1 2026.
32 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.